Synmosa Biopharma Corporation (TPEX:4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.05
0.00 (0.00%)
At close: Mar 26, 2026

Synmosa Biopharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
15,57114,49914,70616,0217,0166,814
Market Cap Growth
11.77%-1.41%-8.21%128.36%2.96%20.87%
Enterprise Value
17,47116,55417,10019,45910,89211,385
Last Close Price
31.0530.6830.7934.7515.0514.33
PE Ratio
19.6621.1824.7220.0523.0910.68
Forward PE
-28.4128.4128.4128.4128.41
PS Ratio
2.552.612.863.652.172.24
PB Ratio
1.571.731.822.411.151.14
P/TBV Ratio
1.902.162.393.381.671.73
P/FCF Ratio
66.3225.6148.2431.9819.3968.14
P/OCF Ratio
32.8818.5728.7325.4215.4226.79
EV/Sales Ratio
2.862.983.334.443.373.75
EV/EBITDA Ratio
15.9215.3818.4325.5822.8325.99
EV/EBIT Ratio
22.8622.3427.7242.2458.3376.15
EV/FCF Ratio
74.4129.2456.0938.8430.10113.85
Debt / Equity Ratio
0.280.300.300.510.570.62
Debt / EBITDA Ratio
2.502.372.564.327.158.30
Debt / FCF Ratio
11.964.507.986.709.5737.02
Net Debt / Equity Ratio
0.060.080.100.290.410.50
Net Debt / EBITDA Ratio
0.540.620.842.555.196.75
Net Debt / FCF Ratio
2.581.182.573.876.8429.56
Asset Turnover
0.470.460.450.410.310.32
Inventory Turnover
1.751.831.991.971.591.74
Quick Ratio
1.521.541.351.100.950.94
Current Ratio
2.452.422.141.731.641.91
Return on Equity (ROE)
6.03%5.68%5.49%9.71%1.93%8.82%
Return on Assets (ROA)
3.76%3.85%3.36%2.68%1.13%0.98%
Return on Invested Capital (ROIC)
5.95%5.87%4.76%4.58%1.61%1.74%
Return on Capital Employed (ROCE)
6.80%7.20%6.40%5.20%2.20%1.70%
Earnings Yield
4.94%4.72%4.04%4.99%4.33%9.37%
FCF Yield
1.51%3.91%2.07%3.13%5.16%1.47%
Dividend Yield
1.76%1.78%1.61%1.31%2.31%1.28%
Payout Ratio
35.41%33.41%32.69%18.60%26.32%7.16%
Buyback Yield / Dilution
-5.14%-3.52%-3.84%0.79%-2.35%-9.76%
Total Shareholder Return
-3.37%-1.74%-2.22%2.10%-0.04%-8.48%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.